C-reactive protein increased and Inflammation

Summary:

Inflammation is found among people with C-reactive protein increased, especially for people who are female, 50-59 old.

The study analyzes which people have Inflammation with C-reactive protein increased. It is created by eHealthMe based on reports of 24 people who have C-reactive protein increased from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is C-reactive protein increased?

C-reactive protein increased is found to be associated with 1,566 drugs and 2,281 conditions by eHealthMe. Check the latest studies of C-reactive protein increased.

What is Inflammation?

Inflammation is found to be associated with 1,709 drugs and 1,873 conditions by eHealthMe. Check the latest studies of Inflammation.

On Jul, 18, 2026

24 people who have C-Reactive Protein Increased and Inflammation are studied.

Would you have Inflammation when you have C-reactive protein increased?

Gender of people who have C-Reactive Protein Increased and experienced Inflammation *:

female: 100 %
male: 0.0 %

Age of people who have C-Reactive Protein Increased and experienced Inflammation *:

Common co-existing conditions for these people *:

Sedation: 15 people, 62.50%
Cardiac Disorder: 11 people, 45.83%
Immune Tolerance Induction: 9 people, 37.50%
Urinary Tract Infection: 5 people, 20.83%
Acute Coronary Syndrome (acute chest pain and other symptoms that happen because the heart does not get blood): 5 people, 20.83%
White Blood Cell Count Increased: 4 people, 16.67%
Fever: 4 people, 16.67%
Escherichia Urinary Tract Infection (urinary tract infection by escherichia coli): 4 people, 16.67%
Non-Small Cell Lung Cancer Stage Iv: 3 people, 12.50%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 2 people, 8.33%

Common drugs taken by these people *:

Clopidogrel: 16 people, 66.67%
Simulect: 16 people, 66.67%
Midazolam: 14 people, 58.33%
Ciclosporin: 14 people, 58.33%
Acetylsalicylic Acid: 12 people, 50.00%
Piperacillin And Tazobactam: 9 people, 37.50%
Envarsus Xr: 4 people, 16.67%
Zykadia: 4 people, 16.67%
Mycophenolate Mofetil: 1 person, 4.17%
Mycophenolic Acid: 1 person, 4.17%

Common symptoms for these people *:

Anaemia (lack of blood): 17 people, 70.83%
Haematoma (collection of blood outside the blood vessels): 16 people, 66.67%
Cardiac Arrest: 16 people, 66.67%
Electrolyte Imbalance: 16 people, 66.67%
Acid Base Balance Abnormal: 16 people, 66.67%
Immunosuppressant Drug Level Increased: 16 people, 66.67%
Cardiogenic Shock (inadequate circulation of blood): 16 people, 66.67%
Pneumonia: 16 people, 66.67%
Cardiac Failure: 16 people, 66.67%
Extremity Necrosis (death of body tissue of arms and legs): 15 people, 62.50%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Inflammation?

- Check whether Inflammation is associated with a drug or a condition

Related studies:

Treatments, associated drugs and conditions:

C-reactive protein increased (52,373 reports)
Inflammation (78,906 reports)

All the drugs that are associated with Inflammation:

Inflammation (1,709 drugs)

All the conditions that are associated with Inflammation:

Inflammation (1,873 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Inflammation and C-reactive protein increased, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.